Butyrate Regulates COVID-19-Relevant Genes in Gut Epithelial Organoids From Normotensive Rats.
作者信息
Li Jing, Richards Elaine M, Handberg Eileen M, Pepine Carl J, Raizada Mohan K
机构信息
From the Department of Physiology and Functional Genomics (J.L., E.M.R., M.K.R.), University of Florida College of Medicine, Gainesville, Florida.
Division of Cardiovascular Medicine, Department of Medicine (E.M.H., C.J.P.), University of Florida College of Medicine, Gainesville, Florida.
出版信息
Hypertension. 2021 Feb;77(2):e13-e16. doi: 10.1161/HYPERTENSIONAHA.120.16647. Epub 2020 Dec 2.
Abstract
摘要
相似文献
1
Butyrate Regulates COVID-19-Relevant Genes in Gut Epithelial Organoids From Normotensive Rats.丁酸盐调节正常血压大鼠肠道上皮类器官中与新冠病毒相关的基因。
Hypertension. 2021 Feb;77(2):e13-e16. doi: 10.1161/HYPERTENSIONAHA.120.16647. Epub 2020 Dec 2.
2
Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of , the Receptor for SARS-CoV-2 Infectivity.无菌大鼠揭示肠道微生物群可调节SARS-CoV-2感染性受体的结肠mRNA。
Hypertension. 2020 Jul;76(1):e1-e3. doi: 10.1161/HYPERTENSIONAHA.120.15360. Epub 2020 May 19.
3
Distinct Gene Expression Profiles in Colonic Organoids from Normotensive and the Spontaneously Hypertensive Rats.正常血压和自发性高血压大鼠结肠类器官中的基因表达谱存在差异。
Cells. 2021 Jun 17;10(6):1523. doi: 10.3390/cells10061523.
4
Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis.定量蛋白质组学分析慢性肠炎患者肠道中 SARS-CoV-2 受体的表达。
Yonsei Med J. 2020 Oct;61(10):891-894. doi: 10.3349/ymj.2020.61.10.891.
5
Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.新型冠状病毒肺炎与血管紧张素转换酶 2 的关系：范围综述。
Adv Exp Med Biol. 2021;1321:53-68. doi: 10.1007/978-3-030-59261-5_5.
6
Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.雌激素调节分化气道上皮细胞中 SARS-CoV-2 受体 ACE2 的表达。
Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1280-L1281. doi: 10.1152/ajplung.00153.2020. Epub 2020 May 20.
7
Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与血管紧张素转换酶2的结合：临床意义
Cardiovasc Res. 2020 Jun 1;116(7):e87-e89. doi: 10.1093/cvr/cvaa096.
8
COVID-19, Renin-Angiotensin System, Angiotensin-Converting Enzyme 2, and Nicotine: What is the Interrelation?新型冠状病毒肺炎、肾素-血管紧张素系统、血管紧张素转换酶2与尼古丁：它们之间有什么相互关系？
Arq Bras Cardiol. 2020 Oct;115(4):708-711. doi: 10.36660/abc.20200653.
9
Angiotensin-converting Enzyme 2 Specific Cell Subset Identification in Oral Tissues: A Need of the Hour in COVID-19 Research.口腔组织中血管紧张素转换酶 2 特异性细胞亚群的鉴定：COVID-19 研究的当务之急。
J Contemp Dent Pract. 2020 Dec 1;21(12):1305-1306.
10
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.心肺疾病中的 ACE2（血管紧张素转换酶 2）：对 SARS-CoV-2 控制的影响。
Hypertension. 2020 Sep;76(3):651-661. doi: 10.1161/HYPERTENSIONAHA.120.15595. Epub 2020 Aug 12.
引用本文的文献
1
Gut microbiota contributes to protection against porcine deltacoronavirus infection in piglets by modulating intestinal barrier and microbiome.肠道微生物群通过调节肠道屏障和微生物组来帮助仔猪抵御猪三角洲冠状病毒感染。
Microbiome. 2025 Apr 7;13(1):93. doi: 10.1186/s40168-025-02092-z.
2
Oral Immunisation With Non-GMO Surface Displayed SARS-CoV-2 Spike Epitopes on Bacteria-Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice.用展示在类细菌颗粒上的非转基因严重急性呼吸综合征冠状病毒2刺突表位进行口服免疫，可激发强烈的体液免疫和细胞免疫反应，并调节小鼠肠道微生物群。
Microb Biotechnol. 2025 Jan;18(1):e70073. doi: 10.1111/1751-7915.70073.
3
Gut microbiota in post-acute COVID-19 syndrome: not the end of the story.新冠后急性综合征中的肠道微生物群：故事尚未结束。
Front Microbiol. 2024 Dec 24;15:1500890. doi: 10.3389/fmicb.2024.1500890. eCollection 2024.
4
Longitudinal Fecal Microbiota Profiles in A Cohort of Non-Hospitalized Adolescents and Young Adults with COVID-19: Associations with SARS-CoV-2 Status and Long-Term Fatigue.一组非住院新冠病毒感染青少年和青年的纵向粪便微生物群概况：与新冠病毒状态及长期疲劳的关联
Pathogens. 2024 Oct 31;13(11):953. doi: 10.3390/pathogens13110953.
5
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation.系统理解人类健康和疾病中微生物组的框架：从基础原理到临床转化。
Signal Transduct Target Ther. 2024 Sep 23;9(1):237. doi: 10.1038/s41392-024-01946-6.
6
Role of short-chain fatty acids in host physiology.短链脂肪酸在宿主生理学中的作用。
Animal Model Exp Med. 2024 Oct;7(5):641-652. doi: 10.1002/ame2.12464. Epub 2024 Jun 28.
7
COVID-19-associated encephalopathy: connection between neuroinflammation and microbiota-gut-brain axis.新型冠状病毒肺炎相关脑病：神经炎症与微生物群-肠-脑轴之间的联系
Front Microbiol. 2024 May 28;15:1406874. doi: 10.3389/fmicb.2024.1406874. eCollection 2024.
8
Short-Chain Fatty Acid (SCFA) as a Connecting Link between Microbiota and Gut-Lung Axis-A Potential Therapeutic Intervention to Improve Lung Health.短链脂肪酸（SCFA）作为微生物群与肠-肺轴之间的连接纽带——改善肺部健康的潜在治疗干预措施
ACS Omega. 2024 Mar 19;9(13):14648-14671. doi: 10.1021/acsomega.3c05846. eCollection 2024 Apr 2.
9
People are an organic unity: Gut-lung axis and pneumonia.人是一个有机整体：肠-肺轴与肺炎。
Heliyon. 2024 Mar 11;10(6):e27822. doi: 10.1016/j.heliyon.2024.e27822. eCollection 2024 Mar 30.
10
Impact of SARS-CoV2 infection on gut microbiota dysbiosis.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对肠道微生物群失调的影响。
Microbiome Res Rep. 2023 Dec 6;3(1):7. doi: 10.20517/mrr.2023.48. eCollection 2024.
本文引用的文献
1
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.MHC Ⅱ类转录激活物 CIITA 诱导细胞抵抗埃博拉病毒和 SARS 样冠状病毒。
Science. 2020 Oct 9;370(6513):241-247. doi: 10.1126/science.abb3753. Epub 2020 Aug 27.
2
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.心肺疾病中的 ACE2（血管紧张素转换酶 2）：对 SARS-CoV-2 控制的影响。
Hypertension. 2020 Sep;76(3):651-661. doi: 10.1161/HYPERTENSIONAHA.120.15595. Epub 2020 Aug 12.
3
SARS-CoV-2 Receptor ACE2 (Angiotensin-Converting Enzyme 2) Is Upregulated in Colonic Organoids From Hypertensive Rats.严重急性呼吸综合征冠状病毒2型受体ACE2（血管紧张素转换酶2）在高血压大鼠的结肠类器官中表达上调。
Hypertension. 2020 Sep;76(3):e26-e28. doi: 10.1161/HYPERTENSIONAHA.120.15725. Epub 2020 Jul 9.
4
Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness.通过阻断 CD14 靶向固有免疫：控制 COVID-19 疾病中炎症和器官功能障碍的新方法。
EBioMedicine. 2020 Jul;57:102836. doi: 10.1016/j.ebiom.2020.102836. Epub 2020 Jun 20.
5
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.宿主对 SARS-CoV-2 的失衡反应导致 COVID-19 的发生。
Cell. 2020 May 28;181(5):1036-1045.e9. doi: 10.1016/j.cell.2020.04.026. Epub 2020 May 15.
Zotero 插件